FDA Drug · D-0746-2026

Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34

Class II · Ongoing

Failed Dissolution Specifications

Affected lots / codes — check yours against thisLot AV5913C, Expiry: 6/2027

Recalling firm: Novartis Pharmaceuticals Corporation, East Hanover, NJ
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: —
Distribution: US Nationwide
Recall initiated: August 4, 2026
Classified: August 7, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0746-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →